BarbaraJEvansMD

Pediatrics • Belle Mead, NJ

Neurodevelopmental Disabilities

Physician

Join to view full profile

Are you Dr. Evans?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 17 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
36 Knickerbocker Dr
Belle Mead, NJ 08502
Phone+1 609-915-4318

Fax+1 908-874-3397
Is this information wrong?

Summary

Dr. Barbara Evans, MD is a board certified pediatrician in Belle Mead, New Jersey. She is currently licensed to practice medicine in New Jersey.

Education & Training

Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1971 - 1973
Tower HealthInternship, Transitional Year, 1968 - 1969
MCP-Hahnemann College of MedicineClass of 1968

Certifications & Licensure

NJ State Medical License 1975 - 2025
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

6 citations
Defending the return of results and data
Susan M. Wolf, Barbara J. Evans> ;Science. 2018 Dec 14
25 citations
Return of results and data to study participants
Susan M. Wolf, Barbara J. Evans> ;Science. 2018 Oct 12
Response to Dreyfus and Sobel.
Barbara J. Evans> ;American Journal of Human Genetics. 2018 Jul 5
20 citations
HIPAA’s Individual Right of Access to Genomic Data: Reconciling Safety and Civil Rights
Barbara J. Evans> ;American Journal of Human Genetics. 2018 Jan 4
8 citations
The Limits of FDA's Authority to Regulate Clinical Research Involving High-Throughput DNA Sequencing.
Barbara J. Evans> ;Food and Drug Law Journal. 2015 Jan 1
21 citations
Regulatory changes raise troubling questions for genomic testing.
Barbara J. Evans, Michael O. Dorschner, Wylie Burke, Gail P. Jarvik> ;Genetics in Medicine. 2014 Sep 25
5 citations
Mining the human genome after Association for Molecular Pathology v. Myriad Genetics
Barbara J. Evans> ;Genetics in Medicine. 2014 Jul 1
282 citations
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
Gail P. Jarvik, Laura M. Amendola, Jonathan S. Berg, Ellen Wright Clayton, Wendy K. Chung, Barbara J. Evans, James P. Evans, Stephanie M. Fullerton, Carlos J. Gallego,...> ;American Journal of Human Genetics. 2014 Jun 5
29 citations
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Barbara J. Evans> ;Genetics in Medicine. 2013 Sep 12
3 citations
Would Patient Ownership of Health Data Improve Confidentiality
Barbara J. Evans> ;The Virtual Mentor. 2012 Sep 1
64 citations
A policy framework for public health uses of electronic health data.
Deven McGraw, Kristen Rosati, Barbara J. Evans> ;Pharmacoepidemiology and Drug Safety. 2012 Jan 1
7 citations
Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Barbara J. Evans> ;Clinical Pharmacology and Therapeutics. 2010 Dec 1
28 citations
Regulating Direct-to-Consumer Personal Genome Testing
Amy L. McGuire, Barbara J. Evans, Timothy Caulfield, Wylie Burke> ;Science. 2010 Oct 8
5 citations
Authority of the Food and Drug Administration to require data access and control use rights in the Sentinel data network.
Barbara J. Evans> ;Food and Drug Law Journal. 2010 Jan 1
8 citations
Finding a liability-free space in which personalized medicine can bloom.
Barbara J. Evans> ;Clinical Pharmacology and Therapeutics. 2007 Oct 1
4 citations
Distinguishing Product and Practice Regulation in Personalized Medicine
Barbara J. Evans> ;Clinical Pharmacology and Therapeutics. 2007 Feb 1
14 citations
Encouraging Translational Research Through Harmonization of FDA and Common Rule Informed Consent Requirements for Research with Banked Specimens
Barbara J. Evans, Eric M. Meslin> ;The Journal of Legal Medicine. 2006 Jun 1
12 citations
What Will It Take to Reap the Clinical Benefits of Pharmacogenomics
Barbara J. Evans> ;Food and Drug Law Journal. 2006 Jan 1
5 citations
The unfinished business of U.S. drug safety regulation.
Barbara J. Evans, David A. Flockhart> ;Food and Drug Law Journal. 2006 Jan 1
8 citations
Creating incentives for genomic research to improve targeting of therapies
Barbara J. Evans, David A. Flockhart, Eric M. Meslin> ;Nature Medicine. 2004 Dec 1
1 citations
Inconsistent regulatory protection under the U.S. Common Rule.
Barbara J. Evans> ;Cambridge Quarterly of Healthcare Ethics. 2004 Oct 1
20 citations
Type 2 Diabetes Mellitus in Youth
Jill L. Quarry-Horn, Barbara J. Evans, James R. Kerrigan> ;The Journal of School Nursing. 2003 Aug 1
2 citations
Type 2 diabetes mellitus: issues for the medical care of pediatric and adult patients.
Michael J. Beck, Barbara J. Evans, Jill L. Quarry-Horn, James R. Kerrigan> ;Southern Medical Journal. 2002 Sep 1
Type 2 diabetes mellitus in adolescents.
Rowell, H.A., Evans, B.J., Quarry-Horn, J.L., Kerrigan, J.R.> ;Adolesc Med. 2002 Feb
Safe management of the child with a contracted neck: a new method.
Wilson RD, Knapp C, Traber DL, Evans B> ;South. Med. J.. 1970-12-01
Join now to see all

Authored Content

Federal COVID-19 Response Unlawfully Blocks State Public Health EffortsOctober 2020